News
News

The latest updates from AFAR.

Grantee in the News: Domenico Praticò’s research on VPS35 Preventing Toxic Tau Buildup in Molecular Psychiatry

Jul 15
2019

Grantee in the News: Domenico Praticò’s research on VPS35 Preventing Toxic Tau Buildup in Molecular Psychiatry View MoreBACK

On July 9, 2019,  Molecular Psychiatry published a study co-authored by AFAR expert Domenico Praticò, MD, that explores how the molecule VPS35 may play a vital role in helping to prevent the buildup of toxic tau, a protein that tends to accumulate in the brains of people with Alzheimer’s disease. This is the first study to show that VPS35 has a role in tauopathy.


Dr. Praticò is a 1997 and 1999 AFAR Research Grant recipient. He is the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, and a Professor and Director of the Alzheimer’s Center at the Lewis Katz School of Medicine at Temple University.


Read an abstract of the article, “VPS35 regulates tau phosphorylation and neuropathology in tauopathy,” here, and read a detailed summary in Medical News Today here.





View MoreBACK TO TOP